Mahkam Zanganeh - Sep 11, 2024 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Co-Chief Executive Officer, Director
Signature
/s/ Mahkam Zanganeh
Stock symbol
SMMT
Transactions as of
Sep 11, 2024
Transactions value $
$999,980
Form type
4
Date filed
9/13/2024, 07:29 PM
Previous filing
Aug 23, 2024
Next filing
Oct 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SMMT Common Stock Award $1M +44.1K +0.18% $22.70 25M Sep 11, 2024 By the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee F1, F2
holding SMMT Common Stock 9.88M Sep 11, 2024 By the Shaun Zanganeh Irrevocable Trust, with the Reporting Person as Trustee. F2
holding SMMT Common Stock 50K Sep 11, 2024 Immediate family member F2
holding SMMT Common Stock 521K Sep 11, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquired in a private placement transaction pursuant to the terms of a definitive agreement, dated as of September 11, 2024, pursuant to which the Issuer agreed to sell shares of common stock to the Mahkam Zanganeh Revocable Trust, with the Reporting Person as Trustee, at a purchase price of $22.70 per share. The transaction closed on September 13, 2024.
F2 The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.